Lung cancer in 2014: optimizing lung cancer treatment approaches
- PMID: 25533943
- DOI: 10.1038/nrclinonc.2014.225
Lung cancer in 2014: optimizing lung cancer treatment approaches
Abstract
In 2014, developments in our understanding of escape signalling circuits implicated in resistance to targeted agents in patients with lung cancer have led to improvements in tackling such resistance. The potential role for PET in the management of erlotinib therapy, novel combination therapies and pharmacogenomic-driven individualization of platinum-based chemotherapy represent other key advances.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
